MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 13, 2021

Total Value ($000): $795,909 (100.0% shares, 0.0% debt)

Holdings (13)

CGEM Cullinan Management, Inc. 41.4%

Value ($000) $329,772 Shares 7,913,887 Est. Cost $40.60 Unrealized 0.0%

— Harpoon Therapeutics, Inc. 10.2%

Value ($000) $81,555 Shares 3,898,422 Est. Cost $14.79 Unrealized —

— iTeos Therapeutics, Inc. 10.1%

Value ($000) $80,513 Shares 2,355,557 Est. Cost $24.67 Unrealized —

— TCR2 Therapeutics, Inc. 9.4%

Value ($000) $74,431 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— Repare Therapeutics, Inc. 8.0%

Value ($000) $63,521 Shares 2,069,749 Est. Cost $31.02 Unrealized —

— MEI Pharma, Inc. 4.4%

Value ($000) $34,773 Shares 10,137,859 Est. Cost $3.11 Unrealized —

— Oncorus, Inc. 4.2%

Value ($000) $33,088 Shares 2,377,031 Est. Cost $32.33 Unrealized —

— Turning Point Therapeutics, Inc. 3.2%

Value ($000) $25,462 Shares 269,186 Est. Cost $44.66 Unrealized —

— G1 Therapeutics, Inc. 2.8%

Value ($000) $22,323 Shares 927,794 Est. Cost $26.43 Unrealized —

— Epizyme, Inc. 2.6%

Value ($000) $20,308 Shares 2,331,534 Est. Cost $22.28 Unrealized —

— Merus N.V. 1.8%

Value ($000) $14,641 Shares 700,879 Est. Cost $16.09 Unrealized —

— YmAbs Therapeutics, Inc. 1.3%

Value ($000) $10,200 Shares 337,291 Est. Cost $31.25 Unrealized —

ADCT ADC Therapeutics, Inc. 0.7%

Value ($000) $5,322 Shares 218,027 Est. Cost $38.22 Unrealized -24.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Management, Inc.	7,913,887	$329,772	41.4%	$40.60	0.0%	Common	230031106
—	Harpoon Therapeutics, Inc.	3,898,422	$81,555	10.2%	$14.79	—	Common	41358P106
—	iTeos Therapeutics, Inc.	2,355,557	$80,513	10.1%	$24.67	—	Common	46565G104
—	TCR2 Therapeutics, Inc.	3,370,982	$74,431	9.4%	$14.28	—	Common	87808K106
—	Repare Therapeutics, Inc.	2,069,749	$63,521	8.0%	$31.02	—	Common	760273102
—	MEI Pharma, Inc.	10,137,859	$34,773	4.4%	$3.11	—	Common	552798202
—	Oncorus, Inc.	2,377,031	$33,088	4.2%	$32.33	—	Common	68236R103
—	Turning Point Therapeutics, Inc.	269,186	$25,462	3.2%	$44.66	—	Common	90041T108
—	G1 Therapeutics, Inc.	927,794	$22,323	2.8%	$26.43	—	Common	3621LQ109
—	Epizyme, Inc.	2,331,534	$20,308	2.6%	$22.28	—	Common	29428V104
—	Merus N.V.	700,879	$14,641	1.8%	$16.09	—	Common	N5749R100
—	YmAbs Therapeutics, Inc.	337,291	$10,200	1.3%	$31.25	—	Common	984241109
ADCT	ADC Therapeutics, Inc.	218,027	$5,322	0.7%	$38.22	-24.2%	Common	H0036K147